The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Improvement of Sjögren's syndrome after two infusions of rituximab (anti‐CD20)
Abstract
Objective: There is evidence to support a dominant role for B cells in the pathophysiology of primary Sjögren's syndrome (SS). Therefore, we evaluated the safety and efficacy of anti‐CD20 monoclonal antibody. Methods: Sixteen patients who met the new American‐European Consensus Group criteria for primary SS and scored >50 on at least 2 of 4 visual analog scales (VAS; 100 mm) evaluating global disease, pain, fatigue, and global dryness received infusions of low‐dose rituximab (375 mg/m 2) at weeks 0 and 1 without steroid premedication. Results: Slow rituximab infusions (100 mg/hour) were well tolerated, with only 1 patient experiencing serum sickness–like disease. There was a dramatic reduction in B cells of the blood and salivary gland (SG). At week 12, VAS scores with respect to fatigue and dryness (P < 0.05), tender point count (P < 0.035), and quality of life as evaluated by the Short Form 36 questionnaire (SF‐36; P < 0.001) were significantly improved. At week 36, significant improvements were noted in the 4 VAS scores (P < 0.05), tender joint count (P = 0.017), tender point count (P = 0.027), and SF‐36 (P < 0.03). Pulmonary manifestations were ameliorated in 1 patient. Patients with improvements on at least 3 of the 4 VAS scores at any visit (n = 11) had a shorter disease duration than the other patients (n = 5; mean ± SD duration 3.8 ± 5.4 versus 30.1 ± 29.5 years; P = 0.02). Conclusion: Low‐dose rituximab infusions were well tolerated without the benefit of steroids. Infusions induced a rapid depletion of B cells in the blood and SG and could improve primary SS. Controlled studies are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H. M., Alexander, E. L., Carsons, S. E., Daniels, T. E., Fox, P. C., Fox, R. I., Kassan, S. S., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.6.554 · Cited by 5,299
McLaughlin, P., Grillo-López, A. J., Link, B. K., Levy, R., Czuczman, M. S., Williams, M. E., Heyman, M. R., Bence-Bruckler, I., White, C. A., Cabanillas, F., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2825 · Cited by 2,755
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
Reff, M., Carner, K., Chambers, K., Chinn, P., Leonard, J., Raab, R., Newman, R., Hanna, N., & Anderson, D. (1994) · Blood · doi:10.1182/blood.v83.2.435.435 · Cited by 1,999
Fox, R. I. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66990-5 · Cited by 1,828
Maloney, D. G., Grillo-López, A. J., White, C. A., Bodkin, D., Schilder, R. J., Neidhart, J. A., Janakiraman, N., Foon, K. A., Liles, T.-M., Dallaire, B. K., et al. (1997) · Blood · doi:10.1182/blood.v90.6.2188 · Cited by 1,733
Characterization of a human B lymphocyte-specific antigen.
Stashenko, P., Nadler, L. M., Hardy, R., & Schlossman, S. F. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.4.1678 · Cited by 1,076
Emery, P., Fleischmann, R., Filipowicz‐Sosnowska, A., Schechtman, J., Szczepanski, L., Kavanaugh, A., Racewicz, A. J., van Vollenhoven, R. F., Li, N. F., Agarwal, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21778 · Cited by 1,060
Labial salivary gland biopsy in Sjögren's disease
Chisholm, D. M., & Mason, D. K. (1968) · Journal of Clinical Pathology · doi:10.1136/jcp.21.5.656 · Cited by 1,017
Coiffier, B., Haïoun, C., Ketterer, N., Engert, A., Tilly, H., Ma, D. D. F., Johnson, P., Lister, A., Feuring‐Buske, M., Radford, J. A., et al. (1998) · PubMed · doi:10.1182/blood.v92.6.1927 · Cited by 893
An open study of B lymphocyte depletion in systemic lupus erythematosus
Leandro, M. J., Edwards, J. C., Cambridge, G., Ehrenstein, M. R., & Isenberg, D. A. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10541 · Cited by 576
Stasi, R., Pagano, A., Stipa, E., & Amadori, S. (2001) · Blood · doi:10.1182/blood.v98.4.952 · Cited by 549
Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes
Edwards, J. C. W., & Cambridge, G. (2001) · Rheumatology · doi:10.1093/rheumatology/40.2.205 · Cited by 523
Rituximab treatment in patients with primary Sjögren's syndrome: An open‐label phase II study
Pijpe, J., van Imhoff, G. W., Spijkervet, F. K. L., Roodenburg, J. L. N., Wolbink, G. J., Mansour, K., Vissink, A., Kallenberg, C. G. M., & Bootsma, H. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21260 · Cited by 500
Mariette, X., Ravaud, P., Steinfeld, S., Baron, G., Goetz, J., Hachulla, E., Combe, B., Puéchal, X., Pennec, Y., Sauvezie, B., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20146 · Cited by 437
Self-citationAnolik, J. H., Campbell, D., Felgar, R. E., Young, F., Sanz, I., Rosenblatt, J., & Looney, R. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10764 · Cited by 429
Piro, L. D., White, C. A., Grillo-López, A. J., Janakiraman, N., Saven, A., Beck, T. M., Varns, C., Shuey, S., Czuczman, M., Lynch, J. W., et al. (1999) · Annals of Oncology · doi:10.1023/a:1008389119525 · Cited by 368
Stott, D. I., Hiepe, F., Hummel, M., Steinhauser, G., & Berek, C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3234 · Cited by 335
Perneger, T. V., Leplège, A., Etter, J.-F., & Rougemont, A. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00227-h · Cited by 314
Hansen, A., Odendahl, M., Reiter, K., Jacobi, A. M., Feist, E., Scholze, J., Burmester, G. R., Lipsky, P. E., & Dörner, T. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10445 · Cited by 271
B cell memory and the long-lived plasma cell
McHeyzer-Williams, M. G., & Ahmed, R. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80029-6 · Cited by 246
Association of patterns of labial salivary gland inflammation with keratoconjunctivitis SICCA
Daniels, T. E., & Whitcher, J. P. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370615 · Cited by 237
Gaston-Johansson, F. (1996) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(96)00128-5 · Cited by 166
Pijpe, J., van Imhoff, G. W., Vissink, A., van der Wal, J. E., Kluin, P. M., Spijkervet, F. K. L., Kallenberg, C. G. M., & Bootsma, H. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.030684 · Cited by 103
BAFF‐induced changes in B cell antigen receptor–containing lipid rafts in Sjögren's syndrome
d’Arbonneau, F., Pers, J., Devauchelle‐Pensec, V., Pennec, Y. L., Saraux, A., & Youinou, P. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21478 · Cited by 74
Self-citationB cell depletion therapy in systemic lupus erythematosus
Anolik, J. H., Sanz, I., & Looney, R. J. (2003) · Current Rheumatology Reports · doi:10.1007/s11926-003-0020-x · Cited by 72
Primary Sjögren's syndrome (pSS): subjective symptoms and salivary findings
Pedersen, A. M. L., Reibel, J., & Nauntofte, B. (1999) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1999.tb02045.x · Cited by 59
Jonsson, R., Gordon, T. P., & Konttinen, Y. T. (2003) · Current Rheumatology Reports · doi:10.1007/s11926-003-0010-z · Cited by 53
Standardization of the Lysozyme Test for a Commercially Available Medium
Bijsterveld, O. P. V. (1974) · Archives of Ophthalmology · doi:10.1001/archopht.1974.03900060446002 · Cited by 47
Cited by
Seror, R., Ravaud, P., Bowman, S. J., Baron, G., Tzioufas, A., Theander, E., Gottenberg, J.-E., Bootsma, H., Mariette, X., & Vitali, C. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.110619 · Cited by 965
EULAR recommendations for the management of Sjogren's syndrome with topical and systemic therapies
Ramos-Casals, M., Brito-Zerón, P., Bombardieri, S., Bootsma, H., De Vita, S., Dörner, T., Fisher, B. A., Gottenberg, J.-E., Hernandez-Molina, G., Kocher, A., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216114 · Cited by 732
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
Furst, D. E., Keystone, E. C., Braun, J., Breedveld, F. C., Burmester, G. R., De Benedetti, F., Dörner, T., Emery, P., Fleischmann, R., Gibofsky, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146852 · Cited by 687
Meijer, J. M., Meiners, P. M., Vissink, A., Spijkervet, F. K. L., Abdulahad, W., Kamminga, N., Brouwer, E., Kallenberg, C. G. M., & Bootsma, H. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27314 · Cited by 488
Treatment of Primary Sjögren Syndrome With Rituximab: A Randomized Trial
Devauchelle-Pensec, V., Mariette, X., Jousse-Joulin, S., Berthelot, J.-M., Perdriger, A., Puéchal, X., Le Guern, V., Sibilia, J., Gottenberg, J.-E., Chiche, L., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1085 · Cited by 429
Metadata
- Authors
- Devauchelle‐Pensec, V., Pennec, Y., Morvan, J., Pers, J., Daridon, C., Jousse‐Joulin, S., Roudaut, A., Jamin, C., Renaudineau, Y., Roué, I. Q., Cochener, B., Youinou, P., & Saraux, A.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2007-02-28
- Volume
- 57
- Issue
- 2
- Pages
- 310-317
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- OpenAlex
- W2024235155
- Cited by
- 315
- References
- 29
- FWCI
- 16.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.